Providing solutions for professionals working in reproductive medicine
David earned a major in Business Science and an MBA from ESADE Business School. He is specialized in International Finance, with over 15 years of experience in consumer goods industries and 8 years in the health care industry. He has developed most of his career internationally, both in Europe and in America, working in Switzerland, US, Mexico and Spain.
He is an executive with broad private and public company backgrounds in both emerging and Fortune 500 companies. During his career, he has hold different responsibilities in Marketing, Finance, Business Development and IT providing him a wide view of business. David has been in general management for the last 8 years. He speaks fluent Spanish, English and French.
Since 2011, he has been the CEO of IGENOMIX, one of the leading companies in providing professional services in advanced molecular diagnoses in the reproductive medicine field.
Business Development Director Middle East & India
Francisco earned his MBA from IE Business School, Madrid and has a high degree in Industrial Engineering from Universidad de Navarra, Spain. He has over 12 years of experience and developed most of his career internationally.
Before joining Igenomix, he began his carrier working for PWC consulting company for more than 4 years, and then started helping leading companies in its internationalization process, establishing new subsidiaries and business units in Europe (Italy, France and Germany), US (California), and Asia (India, Japan and China). He has hold different responsibilities related to Planning and Finance, Business Strategy, Business Development and Marketing, providing him a wide view and experience. He speaks fluent Spanish and English.
For the last years, he has been the Business Developer Director for Asia and CEO of the recently launched subsidiary in India at IGENOMIX, one of the leading companies in providing professional services in advanced molecular diagnoses in the reproductive medicine field. Company belonging to the IVI Group.
Chief Financial Officer
Francisco B. Valor is a senior executive with more than 15 years of experience as a CFO. He has worked in privately-owned multinationals and public-listed companies in the chemical and food manufacturing sectors, as well as the healthcare services industry. He holds a B.A. of Business Administration from the University of Alicante (Spain) and earned his Executive MBA at the IESE Business School. He has extensive experience and knowledge of international and corporate finance and has helped companies go global in MEA, the USA, South America and Asia.
Lab Director Dubai
Dr. Rupali Chopra, PhD in Life Sciences from SMVDU, J&K, India carried out her thesis work under the supervision of Professor R.N.K. Bamezai, renowned Professor of Genetics and Director (Coordinator) National Centre of Applied Human Genetics, SLS, JNU, Delhi. has vast experience in the field of Human Genetics, population genetics, evolutionary genetics, mitochondrial diseases and forensic science with a strong background in Molecular biology, Genetics & Epigenetics.
Her technical expertise lie in a wide range of molecular biology applications with special emphasis on Sequencing, Genotyping, Gene Expression, Methylation analysis. She is also trained in sequencing and genotyping platforms (ABI), MassArray (Sequenom), real time PCR, and robotic workstations.
Her experience includes developing custom panels on Oncology (Mutational and Epigenetic profiling), Infectious disease panels, Prenatal Diseases (Trisomy21, Bthal, CFTR etc). Dr. Rupali has many peer reviewed publications as well.
Sruthi Warrier, Master in Technology in Molecular Medicine from Amrita Centre for Nanosciences and Molecular Medicine (ACNSMM), and Bachelor of technology in Biotechnology from Tamil Nadu Agricultural University.
Her experience includes microbiological and molecular biology studies related to diabetic and cancer patients.
Her technical expertise lie in a wide range of molecular biology applications with special emphasis on XRD, EDAX, RT-PCR, Sequencing, Microscopy, Gene Expression, Cell culture, etc.